Search Page

1

Cite

Share

Carcinogenesis and natural selection: a new perspective to the genetics and epigenetics of colorectal cancer.

Breivik J, Gaudernack G. Breivik J, et al. Adv Cancer Res. 1999;76:187-212. doi: 10.1016/s0065-230x(08)60777-0. Adv Cancer Res. 1999. PMID: 10218102 Review. No abstract available.

Cite

Share

2

Cite

Share

Commentary: cancer--evolution within.

Breivik J. Breivik J. Int J Epidemiol. 2006 Oct;35(5):1161-2. doi: 10.1093/ije/dyl187. Epub 2006 Sep 20. Int J Epidemiol. 2006. PMID: 16990284 No abstract available.

Cite

Share

3

Cite

Share

The evolutionary origin of genetic instability in cancer development.

Breivik J. Breivik J. Semin Cancer Biol. 2005 Feb;15(1):51-60. doi: 10.1016/j.semcancer.2004.09.008. Semin Cancer Biol. 2005. PMID: 15613288 Review.

Cite

Share

4

Cite

Share

Resolving the evolutionary paradox of genetic instability: a cost-benefit analysis of DNA repair in changing environments.

Breivik J, Gaudernack G. Breivik J, et al. FEBS Lett. 2004 Apr 9;563(1-3):7-12. doi: 10.1016/S0014-5793(04)00282-0. FEBS Lett. 2004. PMID: 15063714

Cite

Share

5

Cite

Share

Unstable DNA repair genes shaped by their own sequence modifying phenotypes.

Falster DS, Nakken S, Bergem-Ohr M, Rødland EA, Breivik J. Falster DS, et al. Among authors: breivik j. J Mol Evol. 2010 Mar;70(3):266-74. doi: 10.1007/s00239-010-9328-0. Epub 2010 Mar 6. J Mol Evol. 2010. PMID: 20213140 Free PMC article.

Cite

Share

6

Cite

Share

Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors.

Breivik J, Lothe RA, Meling GI, Rognum TO, Børresen-Dale AL, Gaudernack G. Breivik J, et al. Int J Cancer. 1997 Dec 19;74(6):664-9. doi: 10.1002/(sici)1097-0215(19971219)74:6<664::aid-ijc18>3.0.co;2-5. Int J Cancer. 1997. PMID: 9421366

Cite

Share

7

Cite

Share

K-ras mutations and prognosis in large-bowel carcinomas.

Andersen SN, Løvig T, Breivik J, Lund E, Gaudernack G, Meling GI, Rognum TO. Andersen SN, et al. Among authors: breivik j. Scand J Gastroenterol. 1997 Jan;32(1):62-9. doi: 10.3109/00365529709025065. Scand J Gastroenterol. 1997. PMID: 9018769

Cite

Share

8

Cite

Share

K-ras mutations and HLA-DR expression in large bowel adenomas.

Norheim Andersen S, Breivik J, Løvig T, Meling GI, Gaudernack G, Clausen OP, Schjölberg A, Fausa O, Langmark F, Lund E, Rognum TO. Norheim Andersen S, et al. Among authors: breivik j. Br J Cancer. 1996 Jul;74(1):99-108. doi: 10.1038/bjc.1996.322. Br J Cancer. 1996. PMID: 8679466 Free PMC article.

Cite

Share

9

Cite

Share

Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study.

Gjertsen MK, Bakka A, Breivik J, Saeterdal I, Gedde-Dahl T 3rd, Stokke KT, Sølheim BG, Egge TS, Søreide O, Thorsby E, Gaudernack G. Gjertsen MK, et al. Among authors: breivik j. Int J Cancer. 1996 Feb 8;65(4):450-3. doi: 10.1002/(SICI)1097-0215(19960208)65:4<450::AID-IJC10>3.0.CO;2-E. Int J Cancer. 1996. PMID: 8621226 Clinical Trial.

Cite

Share

10

Cite

Share

K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location.

Breivik J, Meling GI, Spurkland A, Rognum TO, Gaudernack G. Breivik J, et al. Br J Cancer. 1994 Feb;69(2):367-71. doi: 10.1038/bjc.1994.67. Br J Cancer. 1994. PMID: 8297737 Free PMC article.

Cite

Share